Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-03-26

FDA Approved: EUTHYROX — Supplemental Application (Provell Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for EUTHYROX (levothyroxine sodium) from Provell Pharmaceuticals, LLC, indicating a modification to the product labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EUTHYROX (levothyroxine sodium)

Snippet

SUPPL AP for EUTHYROX (LEVOTHYROXINE SODIUM)